Drug:
Reaction: GENERAL PHYSICAL HEALTH DETERIORATION
20250101 - 20251231
No. 1501 - 1600
No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
1501 | 24897504 |
CA |
44 | 2 |
Osteoporosis, Pneumonia, Prescribed underdose, Pulmonary fibrosis, Red blood cell sedimentation rate increased, Retinitis, Tachycardia, Therapeutic product effect incomplete, Thrombocytopenia, Visual impairment, Fatigue, Fibromyalgia, Folliculitis, Gait inability, Gastrointestinal disorder, Glossodynia, Hand deformity, Headache, Helicobacter infection, Hypersensitivity, C-reactive protein abnormal, Dry mouth, Duodenal ulcer perforation, Facet joint syndrome, General physical health deterioration, Hepatic enzyme increased, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Infection, Inflammation, Infusion related reaction, Injury, Insomnia, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Liver disorder, Malaise, Mobility decreased, Pruritus, Psoriatic arthropathy, Pyrexia, Rash, Rheumatic fever, Rheumatoid arthritis, Rheumatoid factor positive, Road traffic accident, Sciatica, Sinusitis, Sleep disorder, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Swelling, Swollen joint count increased, Synovitis, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Wheezing, Wound, C-reactive protein, Drug ineffective, Drug intolerance, Medication error, Product use in unapproved indication, Systemic lupus erythematosus, Therapeutic product effect decreased, Therapy non-responder, Treatment failure, Abdominal pain upper, Anti-cyclic citrullinated peptide antibody, Breast cancer stage III, Bursitis, Confusional state, Diarrhoea, Dizziness, Exposure during pregnancy, Live birth, Memory impairment, Nausea, Oedema, Oedema peripheral, Pain in extremity, Pregnancy, Off label use, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, GOLIMUMAB, USTEKINUMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, PREDNISONE, PREDNISONE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, HYDROXYCHLOROQUINE, TOCILIZUMAB, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, CALCIUM CARBONATE, ANTACID, CELECOXIB, SECUKINUMAB, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, PREGABALIN, PREGABALIN, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, APREMILAST, VITAMIN C, VITAMIN C, NEOMYCIN SULFATE, NYSTATIN, NYSTATIN OINTMENT, NYSTATIN CREAM, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, ALENDRONATE SODIUM, FOSAPREPITANT, FOSAPREPITANT DIMEGLUMINE, HYDROCORTISONE SODIUM SUCCINATE, NAPROXEN, NAPROXEN SODIUM, PHENYLEPHRINE HYDROCHLORIDE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, MESALAMINE, ACETAMINOPHEN,CAFFEINE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, TRAMADOL HYDROCHLORIDE, CERTOLIZUMAB PEGOL, DESOXIMETASONE, ABATACEPT, ABATACEPT, LISINOPRIL, QUETIAPINE FUMARATE, QUETIAPINE, AZATHIOPRINE, CAFFEINE, ASCORBIC ACID, CALCIUM GLUCONATE, DESOGESTREL AND ETHINYL ESTRADIOL, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, ERYTHROMYCIN, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LISINOPRIL, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, RAMIPRIL, RISEDRONATE SODIUM, |
||||
1502 | 24897830 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
1503 | 24897831 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
1504 | 24897832 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
1505 | 24897889 |
CA |
55 | 1 |
Glaucoma, General physical health deterioration, |
||||
RISANKIZUMAB-RZAA, |
||||
1506 | 24897953 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
1507 | 24898002 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 DOTATATE, |
||||
1508 | 24898162 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
1509 | 24898164 |
PT |
41 | 2 |
General physical health deterioration, Hypovolaemic shock, Pulmonary embolism, Right ventricular dilatation, Haemoperitoneum, Systolic dysfunction, Traumatic liver injury, |
||||
TENECTEPLASE, |
||||
1510 | 24898241 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
1511 | 24898306 |
US |
1 | |
General physical health deterioration, Hospice care, |
||||
PIMAVANSERIN TARTRATE, |
||||
1512 | 24898455 |
FR |
44 | 2 |
Drug use disorder, Overdose, General physical health deterioration, Fall, |
||||
RISPERIDONE, DIAZEPAM, |
||||
1513 | 24898735 |
CA |
||
Abdominal discomfort, Abdominal pain, Abdominal pain upper, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Blepharospasm, Blister, Blood cholesterol increased, Breast cancer stage III, Bursitis, C-reactive protein increased, Condition aggravated, Confusional state, Depression, Diarrhoea, Discomfort, Dizziness, Dry mouth, Duodenal ulcer perforation, Epilepsy, Facet joint syndrome, Fatigue, Fibromyalgia, Folliculitis, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Hand deformity, Helicobacter infection, Hepatic enzyme, Hypercholesterolaemia, Hypertension, Hypoaesthesia, Impaired healing, Inflammation, Infusion related reaction, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Liver injury, Lower respiratory tract infection, Lung disorder, Memory impairment, Migraine, Muscle injury, Muscle spasms, Musculoskeletal pain, Nail disorder, Nasopharyngitis, Night sweats, Obesity, Osteoarthritis, Pain, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Psoriatic arthropathy, Rash, Rheumatoid arthritis, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Taste disorder, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Wheezing, Wound, Wound infection, Drug intolerance, Maternal exposure during pregnancy, Product quality issue, Drug ineffective, Product use in unapproved indication, Intentional product use issue, Off label use, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ACETAMINOPHEN AND CODEINE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, TOCILIZUMAB, ERENUMAB-AOOE, APREMILAST, APREMILAST, LEFLUNOMIDE, ATOMOXETINE HYDROCHLORIDE, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, CANDESARTAN, CELECOXIB, CELECOXIB, CERTOLIZUMAB PEGOL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, SECUKINUMAB, DESOXIMETASONE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ETANERCEPT, ETANERCEPT, ERENUMAB-AOOE, FOLIC ACID, ALENDRONATE SODIUM, GOLD, HYDROCORTISONE BUTYRATE, HYDROXYCHLOROQUINE SULFATE, LAMOTRIGINE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MIRABEGRON, METHOTREXATE SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, MEPOLIZUMAB, ABATACEPT, OXYCODONE, POVIDONE-IODINE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, RAMIPRIL, RANITIDINE, INFLIXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, SULFASALAZINE, TOFACITINIB, TOPIRAMATE, TOPIRAMATE SPINKLE, TRAMADOL HYDROCHLORIDE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, LORAZEPAM, CALCIUM GLUCONATE, CYANOCOBALAMIN, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LANSOPRAZOLE, LISINOPRIL, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, QUETIAPINE FUMARATE, QUETIAPINE, RISEDRONATE SODIUM, SULFASALAZINE, FISH OIL, CALCIUM, |
||||
1514 | 24898829 |
US |
76 | 2 |
Oxygen saturation decreased, General physical health deterioration, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TADALAFIL, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, IRON, CALCITRIOL, CALCITRIOL CAPSULES 0.25 MCG, CALCITRIOL CAPSULES 0.5 MCG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, OXYGEN, 0XYGEN, FUROSEMIDE, TORSEMIDE, |
||||
1515 | 24898908 |
CA |
44 | 2 |
C-reactive protein, Drug intolerance, Dry mouth, Duodenal ulcer perforation, Facet joint syndrome, Fatigue, Fibromyalgia, Folliculitis, General physical health deterioration, Glossodynia, Hand deformity, Helicobacter infection, Hepatic enzyme increased, Hypersensitivity, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Infection, Inflammation, Infusion related reaction, Injury, Insomnia, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Liver disorder, Lip dry, Malaise, Mobility decreased, Pruritus, Psoriatic arthropathy, Pyrexia, Rash, Rheumatic fever, Rheumatoid arthritis, Rheumatoid factor positive, Road traffic accident, Sciatica, Sinusitis, Sleep disorder, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Swelling, Swollen joint count increased, Synovitis, Systemic lupus erythematosus, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Wheezing, Wound, Abdominal discomfort, Abdominal pain upper, Adjustment disorder with depressed mood, Alopecia, Amnesia, Anti-cyclic citrullinated peptide antibody positive, Anxiety, Arthralgia, Arthropathy, Asthenia, Asthma, Autoimmune disorder, Blister, Blood cholesterol increased, Breast cancer stage II, C-reactive protein abnormal, Chest pain, Condition aggravated, Confusional state, Contusion, Decreased appetite, Deep vein thrombosis postoperative, Delirium, Depression, Diarrhoea, Discomfort, Dislocation of vertebra, Drug hypersensitivity, Muscle injury, X-ray abnormal, Wound infection, Osteoarthritis, Weight decreased, Peripheral venous disease, Peripheral swelling, Pericarditis, Pemphigus, Paraesthesia, Pain, Oedema, Obesity, Night sweats, Nasopharyngitis, Musculoskeletal stiffness, Musculoskeletal pain, Muscular weakness, Memory impairment, Muscle spasms, Migraine, Liver injury, Lupus vulgaris, Lung disorder, Lower respiratory tract infection, Lower limb fracture, Loss of personal independence in daily activities, Live birth, Knee arthroplasty, Headache, Grip strength decreased, Gait disturbance, Hip arthroplasty, Gastrointestinal disorder, Gait inability, Folliculitis, Dyspnoea, Dyspepsia, Drug-induced liver injury, Crohn^s disease, Ear infection, Exostosis, Foot deformity, Hepatic cirrhosis, Hypercholesterolaemia, Joint dislocation, Lupus-like syndrome, Laryngitis, Drug ineffective, Therapy non-responder, Treatment failure, Therapeutic product effect decreased, Maternal exposure during pregnancy, Intentional product misuse, Product use issue, Off label use, Product use in unapproved indication, Contraindicated product administered, Prescribed overdose, Medication error, Maternal exposure timing unspecified, Abdominal pain, Arthritis, Bursitis, Colitis ulcerative, Dizziness, Frequent bowel movements, Laboratory test abnormal, Nausea, Oedema peripheral, Osteoporosis, Pancreatitis, Pneumonia, Porphyria acute, Rectal haemorrhage, Retinitis, Visual impairment, Walking aid user, White blood cell count increased, Bone erosion, Pain in extremity, Underdose, Breast cancer stage III, Feeling hot, Thrombocytopenia, Intentional product use issue, Prescribed underdose, Pulmonary fibrosis, Red blood cell sedimentation rate increased, Tachycardia, Therapeutic product effect incomplete, |
||||
PREGABALIN, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ALENDRONATE SODIUM, SULFASALAZINE, SULFASALAZINE, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, METHOTREXATE, METHOTREXATE SODIUM, |
||||
1516 | 24899612 |
CA |
2 | |
Abdominal discomfort, Abdominal pain upper, Adjustment disorder with depressed mood, Alopecia, Amnesia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Back disorder, Blister, Blood cholesterol increased, Breast cancer stage II, Chest pain, Condition aggravated, Confusional state, Decreased appetite, Delirium, Depression, Diarrhoea, Disability, Discomfort, Dislocation of vertebra, Drug hypersensitivity, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Fatigue, Fibromyalgia, Fluid retention, Folliculitis, Gait disturbance, Gait inability, Gastrointestinal disorder, General physical health deterioration, General symptom, Glossodynia, Grip strength decreased, Hand deformity, Headache, Helicobacter infection, Hepatic enzyme increased, Hip arthroplasty, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Infection, Infusion related reaction, Injury, Irritable bowel syndrome, Joint swelling, Joint range of motion decreased, Knee arthroplasty, Liver injury, Lower respiratory tract infection, Malaise, Memory impairment, Migraine, Mobility decreased, Muscle injury, Musculoskeletal stiffness, Myositis, Nasopharyngitis, Nausea, Oedema, Pain, Pain in extremity, Pemphigus, Pericarditis, Peripheral swelling, Pneumonia, Pruritus, Psoriasis, Psoriatic arthropathy, Pulmonary fibrosis, Pustular psoriasis, Pyrexia, Rash, Rash vesicular, Rheumatic fever, Rheumatoid arthritis, Rheumatoid factor positive, Sinusitis, Sleep disorder, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Subcutaneous drug absorption impaired, Swelling, Swollen joint count increased, Synovitis, Systemic lupus erythematosus, Type 2 diabetes mellitus, Urticaria, Vomiting, Walking aid user, Weight decreased, Weight increased, Wheezing, Wound, Wound infection, X-ray abnormal, Contusion, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN AND CODEINE, ACETAMINOPHEN AND CODEINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ALENDRONATE SODIUM, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, LEFLUNOMIDE, LEFLUNOMIDE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, SECUKINUMAB, SECUKINUMAB, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, ETANERCEPT, ETANERCEPT, ETANERCEPT, VEDOLIZUMAB, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ADALIMUMAB, ADALIMUMAB, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, INFLIXIMAB, INFLIXIMAB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, SARILUMAB, SARILUMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, OXYCODONE HYDROCHLORIDE, OXYCODONE, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, APREMILAST, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, UPADACITINIB, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, CALCIUM CARBONATE, CALCIUM CARBONATE, PREDNISONE, PREDNISONE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, LORAZEPAM, LORAZEPAM, CAFFEINE CITRATE, CAFFEINE CITRATE, CALCIUM GLUCONATE, CALCIUM GLUCONATE, ERGOCALCIFEROL, ERGOCALCIFEROL, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LANSOPRAZOLE, LISINOPRIL, LISINOPRIL, LORAZEPAM, LORAZEPAM, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, RAMIPRIL, RAMIPRIL, SULFASALAZINE, SULFASALAZINE, FISH OIL, FISH OIL, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, |
||||
1517 | 24899636 |
GB |
69 | 1 |
Hypogammaglobulinaemia, Progressive multifocal leukoencephalopathy, Toxoplasmosis, Memory impairment, Cognitive disorder, General physical health deterioration, |
||||
RITUXIMAB, RITUXIMAB, DOXORUBICIN, DOXORUBICIN, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, |
||||
1518 | 24899976 |
US |
74 | 1 |
Bendopnoea, Increased upper airway secretion, Cough, Throat irritation, Dyspnoea exertional, General physical health deterioration, Decreased activity, Chest pain, Fatigue, Peripheral swelling, Joint swelling, Affective disorder, |
||||
AMBRISENTAN, TREPROSTINIL, |
||||
1519 | 24900120 |
AT |
57 | 1 |
Therapeutic product effect incomplete, Amyloidosis, Quadriplegia, General physical health deterioration, Hypertension, Off label use, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DARATUMUMAB, CARFILZOMIB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, |
||||
1520 | 24900198 |
CA |
75 | 2 |
Shoulder fracture, Wrist fracture, Back pain, Musculoskeletal stiffness, Fear of injection, Joint stiffness, Pain in extremity, Weight decreased, Nasopharyngitis, Needle track marks, General physical health deterioration, Corneal disorder, Tremor, Arthralgia, Injection site pain, Injection site haemorrhage, Injection site pain, Loss of personal independence in daily activities, Product dose omission issue, Product use complaint, |
||||
ETANERCEPT, METHOTREXATE, METHOTREXATE SODIUM, HYDROXYCHLOROQUINE SULFATE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
1521 | 24900694 |
US |
||
Disease progression, Malaise, General physical health deterioration, Illness, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
1522 | 24900728 |
US |
2 | |
General physical health deterioration, Influenza, |
||||
LUTETIUM LU 177 DOTATATE, |
||||
1523 | 24900745 |
FR |
90 | 1 |
Interstitial lung disease, Loss of personal independence in daily activities, General physical health deterioration, Cognitive disorder, Decreased appetite, Disorientation, Fall, |
||||
EZETIMIBE, SILODOSIN, |
||||
1524 | 24900782 |
CA |
40 | 2 |
Abdominal discomfort, Abdominal pain upper, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Blood cholesterol increased, Bursitis, C-reactive protein increased, Confusional state, Decreased appetite, Drug intolerance, Drug-induced liver injury, Dyspnoea, Fatigue, Folliculitis, Gastrointestinal disorder, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Hand deformity, Hepatic enzyme increased, Hypertension, Hypoaesthesia, Ill-defined disorder, Inflammation, Injection site reaction, Joint swelling, Maternal exposure during pregnancy, Mobility decreased, Off label use, Synovitis, Systemic lupus erythematosus, Taste disorder, Therapeutic product effect decreased, Therapeutic product effect incomplete, Treatment failure, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Wheezing, Wound, Wound infection, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, LEFLUNOMIDE, AZATHIOPRINE, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, CELECOXIB, CELECOXIB, CELECOXIB, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, HYDROCORTISONE, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ERENUMAB-AOOE, ERGOCALCIFEROL, ERGOCALCIFEROL, ERGOCALCIFEROL, GOLIMUMAB, GOLIMUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE ACETATE, ADALIMUMAB-ADAZ, INFLIXIMAB, SARILUMAB, LAMOTRIGINE, METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MIRABEGRON, NAPROXEN, NAPROXEN SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, MEPOLIZUMAB, PHENYLEPHRINE HYDROCHLORIDE, PREDNISONE, PREDNISONE, RAMIPRIL, RANITIDINE HYDROCHLORIDE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, SULFASALAZINE, APREMILAST, APREMILAST, APREMILAST, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, TOFACITINIB, TOPIRAMATE, TOPIRAMATE SPINKLE, TRAMADOL HYDROCHLORIDE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, USTEKINUMAB-AEKN, USTEKINUMAB-AEKN, USTEKINUMAB-AEKN, VITAMIN C, ERGOCALCIFEROL, |
||||
1525 | 24900888 |
CA |
97 | 2 |
Ill-defined disorder, Hypoaesthesia, Hypersensitivity, Hypertension, Hypercholesterolaemia, Hepatic enzyme increased, Headache, Hand deformity, Grip strength decreased, Glossodynia, General symptom, General physical health deterioration, Gait inability, Gastrointestinal disorder, Folliculitis, Fluid retention, Fibromyalgia, Fatigue, Dyspnoea, Dyspepsia, Drug hypersensitivity, Discomfort, Diarrhoea, Depression, Contusion, Confusional state, Condition aggravated, Chest pain, Blood cholesterol increased, Blister, Back disorder, Arthropathy, Gait disturbance, Decreased appetite, |
||||
SECUKINUMAB, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC SODIUM, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, OXYCODONE HYDROCHLORIDE, OXYCODONE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, CALCIUM CARBONATE, ACETAMINOPHEN AND DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN AND CAFFEINE, ACETAMINOPHEN AND PHENYLEPRINE HCL, ACETAMINOPHEN AND DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN AND CAFFEINE, ACETAMINOPHEN AND PHENYLEPRINE HCL, ACETAMINOPHEN AND CODEINE, ASCORBIC ACID, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, VEDOLIZUMAB, |
||||
1526 | 24901107 |
US |
2 | |
Constipation, General physical health deterioration, |
||||
LINACLOTIDE, |
||||
1527 | 24901211 |
CA |
80 | 1 |
Anaemia, Bone cancer, General physical health deterioration, Muscle spasms, Nausea, Vomiting, Weight decreased, Weight increased, |
||||
MORPHINE SULFATE, LEUPROLIDE ACETATE, |
||||
1528 | 24901224 |
CA |
43 | 2 |
Liver injury, Epilepsy, Systemic lupus erythematosus, Type 2 diabetes mellitus, Pericarditis, Duodenal ulcer perforation, Pemphigus, Breast cancer stage III, Psoriatic arthropathy, Lower respiratory tract infection, Rheumatoid arthritis, Wound infection, Helicobacter infection, Abdominal pain, Abdominal pain upper, Abdominal discomfort, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Nail disorder, Swelling, Stomatitis, General physical health deterioration, Migraine, Muscle injury, Muscle spasms, Musculoskeletal pain, Lip dry, Lung disorder, Rash, Memory impairment, Paraesthesia, Taste disorder, Osteoarthritis, Fibromyalgia, Facet joint syndrome, Condition aggravated, Confusional state, Maternal exposure during pregnancy, |
||||
DICLOFENAC SODIUM, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ERENUMAB-AOOE, SECUKINUMAB, CANDESARTAN, OXYCODONE, RITUXIMAB, RITUXIMAB, TRAMADOL HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN AND CODEINE, TOCILIZUMAB, APREMILAST, LEFLUNOMIDE, ATOMOXETINE HYDROCHLORIDE, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, CELECOXIB, CERTOLIZUMAB PEGOL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, DESOXIMETASONE, ETANERCEPT, FOLIC ACID, ALENDRONATE SODIUM, GOLD, HYDROCORTISONE BUTYRATE, HYDROXYCHLOROQUINE SULFATE, LAMOTRIGINE, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MIRABEGRON, LORAZEPAM, CALCIUM, CYANOCOBALAMIN, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
1529 | 24901421 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
1530 | 24901442 |
CA |
1 | |
Death, Weight decreased, General physical health deterioration, |
||||
IBRUTINIB, IBRUTINIB, IBRUTINIB, |
||||
1531 | 24901482 |
SE |
87 | 2 |
Urinary retention, General physical health deterioration, Somnolence, Acute kidney injury, |
||||
RISPERIDONE, |
||||
1532 | 24901518 |
US |
1 | |
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
1533 | 24902056 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
1534 | 24902057 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
1535 | 24902125 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
1536 | 24902164 |
CA |
43 | 2 |
Liver injury, Hand deformity, Facet joint syndrome, Systemic lupus erythematosus, Taste disorder, Folliculitis, Dizziness, Blepharospasm, Arthralgia, Peripheral swelling, Asthenia, Peripheral venous disease, Discomfort, Maternal exposure during pregnancy, Intentional product use issue, Diarrhoea, Helicobacter infection, Joint range of motion decreased, Duodenal ulcer perforation, Gastrooesophageal reflux disease, Depression, Infusion related reaction, Irritable bowel syndrome, Joint swelling, Rheumatoid arthritis, General physical health deterioration, Swelling, Obesity, Psoriatic arthropathy, Muscle injury, Wound, Drug intolerance, Type 2 diabetes mellitus, Wound infection, Weight increased, Fatigue, Wheezing, Dry mouth, Blister, Hypercholesterolaemia, Abdominal pain, Alopecia, Synovitis, Anti-cyclic citrullinated peptide antibody positive, Drug ineffective, Epilepsy, Pain, Breast cancer stage III, Hypoaesthesia, Pericarditis, Urticaria, Nail disorder, Fibromyalgia, Confusional state, Inflammation, Muscle spasms, Migraine, Bursitis, Stomatitis, Lung disorder, Vomiting, Osteoarthritis, Off label use, Product quality issue, Rash, Impaired healing, Glossodynia, Memory impairment, Abdominal discomfort, Lower respiratory tract infection, Night sweats, Arthropathy, Paraesthesia, Lip dry, C-reactive protein increased, Musculoskeletal pain, Hypertension, Abdominal pain upper, Nasopharyngitis, Product use in unapproved indication, Pemphigus, Hepatic enzyme, Blood cholesterol increased, Condition aggravated, |
||||
RAMIPRIL, TOFACITINIB, TOFACITINIB, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, DESOXIMETASONE, PREDNISONE, TOPIRAMATE, TOPIRAMATE SPINKLE, TRAMADOL HYDROCHLORIDE, INFLIXIMAB, CELECOXIB, CELECOXIB, LANSOPRAZOLE, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, LAMOTRIGINE, HYDROCORTISONE BUTYRATE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CALCIUM, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, LORAZEPAM, FISH OIL, RITUXIMAB, RITUXIMAB, METHOTREXATE, METHOTREXATE SODIUM, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, RISEDRONATE SODIUM, ERENUMAB-AOOE, APREMILAST, TOCILIZUMAB, SULFASALAZINE, HYDROXYCHLOROQUINE SULFATE, ATOMOXETINE HYDROCHLORIDE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, ABATACEPT, CYANOCOBALAMIN, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, BOTULINUM TOXIN TYPE A, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, LISINOPRIL, QUETIAPINE FUMARATE, QUETIAPINE, ALENDRONATE SODIUM, MEPOLIZUMAB, LEFLUNOMIDE, FOLIC ACID, CERTOLIZUMAB PEGOL, ETANERCEPT, NAPROXEN, NAPROXEN SODIUM, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, BUPRENORPHINE, OXYCODONE, OXYCODONE, SECUKINUMAB, GOLIMUMAB, GOLIMUMAB, CANDESARTAN, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, MIRABEGRON, SULFASALAZINE, RITUXIMAB, RITUXIMAB, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, |
||||
1537 | 24892124 |
IT |
||
Necrotising colitis, Urine abnormality, Chromaturia, Flatulence, Blood test abnormal, Gastric dilatation, Abdominal distension, Haemoperitoneum, Hypotension, Pyrexia, Respiratory failure, General physical health deterioration, Immunosuppression, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, VINCRISTINE SULFATE, PREDNISONE, PREDNISONE, OXYGEN, 0XYGEN, FENTANYL, ALBUMIN HUMAN, CHLORPHENIRAMINE MALEATE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, FILGRASTIM, PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM, PIPERACILLIN AND TAZOBACTAM, PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, RASBURICASE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, BECLOMETHASONE DIPROPIONATE, FUROSEMIDE, PANTOPRAZOLE, ACYCLOVIR, PALONOSETRON, PALONOSETRON HYDROCHLORIDE, ALPRAZOLAM, CEFTRIAXONE, CEFTRIAXONE SODIUM, LINEZOLID, MEROPENEM, VORICONAZOLE, ZOLEDRONIC ACID, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, AMPHOTERICIN B, INSULIN HUMAN, ACETYLCYSTEINE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, TOCILIZUMAB, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, NEOSTIGMINE METHYLSULFATE, CALCIUM GLUCONATE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, CALCIUM CHLORIDE INJECTION, CALCIUM CHLORIDE, |
||||
1538 | 24892295 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
1539 | 24892638 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
1540 | 24892907 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 DOTATATE, |
||||
1541 | 24893107 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
1542 | 24893206 |
FR |
77 | |
Azotaemia, Aortic valve incompetence, Hypercalcaemia, Drug interaction, General physical health deterioration, Clinomania, Hypovolaemia, |
||||
OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, PREDNISONE, CALCIUM ACETATE, CALCIUM ACETATE CAPSULES 667 MG, BISOPROLOL FUMARATE, LEVOTHYROXINE, AMLODIPINE, FUROSEMIDE, FERROUS SULFATE, DARBEPOETIN ALFA, SODIUM BICARBONATE, SODIUM BICARBONATE INJECTION,, VALSARTAN, |
||||
1543 | 24893215 |
DE |
57 | 2 |
Hypersensitivity, Pruritus, Urticaria, Flushing, General physical health deterioration, Hypotension, |
||||
ALBUMIN HUMAN, BISOPROLOL FUMARATE, DALFAMPRIDINE, FOLIC ACID, DALTEPARIN SODIUM, |
||||
1544 | 24893487 |
DE |
1 | |
General physical health deterioration, Haemorrhagic stroke, Sepsis, Parkinson^s disease, |
||||
QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, LACTULOSE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ESCITALOPRAM OXALATE, ESCITALOPRAM, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, PANTOPRAZOLE, |
||||
1545 | 24893502 |
AT |
57 | 1 |
Amyloidosis, Quadriplegia, General physical health deterioration, Hypertension, |
||||
DARATUMUMAB, DARATUMUMAB, DARATUMUMAB, DARATUMUMAB, DARATUMUMAB, DARATUMUMAB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, CARFILZOMIB, CARFILZOMIB, CARFILZOMIB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, |
||||
1546 | 24893835 |
DE |
1 | |
Death, General physical health deterioration, Infusion site erythema, Derailment, Product knowledge deficit, |
||||
FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, |
||||
1547 | 24894190 |
FR |
65 | 1 |
Septic shock, Acute kidney injury, Dyspnoea exertional, Asthenia, Systemic inflammatory response syndrome, Malignant neoplasm progression, Toxicity to various agents, General physical health deterioration, Proctalgia, Dysphagia, Hyperuricaemia, Pancytopenia, Hypotension, Diarrhoea, Febrile bone marrow aplasia, |
||||
CARBOPLATIN, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMETREXED DISODIUM, PEMETREXED DISODIUM, PEMETREXED DISODIUM, PEMETREXED DISODIUM, PEMETREXED DISODIUM, PEMETREXED DISODIUM, PEMETREXED DISODIUM, PEMETREXED DISODIUM, PEMETREXED DISODIUM, FENTANYL, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, BISOPROLOL FUMARATE, ROSUVASTATIN, OXYCODONE HYDROCHLORIDE, OXYCODONE, |
||||
1548 | 24894839 |
CA |
43 | 2 |
Abdominal discomfort, Abdominal pain upper, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Blepharospasm, Blister, Blood cholesterol increased, Breast cancer stage III, Bursitis, C-reactive protein increased, Condition aggravated, Confusional state, Decreased appetite, Depression, Diarrhoea, Dizziness, Dry mouth, Duodenal ulcer perforation, Epilepsy, Facet joint syndrome, Fatigue, Fibromyalgia, Folliculitis, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Hand deformity, Headache, Helicobacter infection, Hepatic enzyme increased, Hypertension, Hypoaesthesia, Hypocholesterolaemia, Impaired healing, Inflammation, Infusion related reaction, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Live birth, Liver injury, Lower respiratory tract infection, Lung disorder, Memory impairment, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Musculoskeletal pain, Nail disorder, Nasopharyngitis, Night sweats, Obesity, Osteoarthritis, Pain, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Psoriatic arthropathy, Rash, Rheumatoid arthritis, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Taste disorder, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Wheezing, Wound, Wound infection, Maternal exposure during pregnancy, Exposure during pregnancy, Contraindicated product administered, Product quality issue, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ATOMOXETINE HYDROCHLORIDE, ACETAMINOPHEN AND CODEINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ERENUMAB-AOOE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, PREDNISONE, PREDNISONE, LEFLUNOMIDE, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, CANDESARTAN, CANDESARTAN, CANDESARTAN, CELECOXIB, CELECOXIB, CALCIUM, CALCIUM CARBONATE, ANTACID, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, CORTISONE ACETATE, SECUKINUMAB, SECUKINUMAB, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DESOXIMETASONE, DEXPANTHENOL, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, ETANERCEPT, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE SULFATE, SARILUMAB, LEFLUNOMIDE, LEFLUNOMIDE, LAMOTRIGINE, LAMOTRIGINE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MIRABEGRON, NAPROXEN, NAPROXEN SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, MEPOLIZUMAB, OXYCODONE, ABATACEPT, ABATACEPT, APREMILAST, PHENYLEPHRINE HYDROCHLORIDE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PYRIDOXINE HYDROCHLORIDE, PYRIDOXINE HYDROCHLORIDE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RAMIPRIL, RANITIDINE HYDROCHLORIDE, INFLIXIMAB, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOFACITINIB, TOPIRAMATE, TOPIRAMATE, TOPIRAMATE, TRAMADOL HYDROCHLORIDE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, VITAMIN C, TOFACITINIB, TOFACITINIB, LORAZEPAM, CYANOCOBALAMIN, ICOSAPENT ETHYL, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LANSOPRAZOLE, LISINOPRIL, LORAZEPAM, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, QUETIAPINE FUMARATE, QUETIAPINE, RISEDRONATE SODIUM, FISH OIL, |
||||
1549 | 24894891 |
US |
||
General physical health deterioration, |
||||
ELRANATAMAB-BCMM, |
||||
1550 | 24894925 |
TH |
76 | 2 |
General physical health deterioration, Off label use, |
||||
AXITINIB, AXITINIB, |
||||
1551 | 24895200 |
US |
||
Ill-defined disorder, General physical health deterioration, |
||||
LUTETIUM LU 177 DOTATATE, |
||||
1552 | 24895408 |
CA |
44 | 2 |
Abdominal discomfort, Blood cholesterol increased, Joint swelling, Asthenia, Peripheral venous disease, Muscle spasms, Blister, Dizziness, Musculoskeletal pain, Nasopharyngitis, Decreased appetite, Joint range of motion decreased, Anti-cyclic citrullinated peptide antibody positive, Pyrexia, Sleep disorder, Adjustment disorder with depressed mood, Fibromyalgia, Pain, Synovitis, Contusion, Duodenal ulcer perforation, Night sweats, Hand deformity, Peripheral swelling, Inflammation, Osteoarthritis, Colitis ulcerative, C-reactive protein abnormal, General physical health deterioration, Pemphigus, Weight decreased, Amnesia, Oedema, Hepatic enzyme increased, Drug hypersensitivity, Irritable bowel syndrome, Lung disorder, Dry mouth, Musculoskeletal stiffness, Paraesthesia, Systemic lupus erythematosus, Swelling, Drug intolerance, Injury, Porphyria acute, Alopecia, Folliculitis, Muscle injury, Feeling hot, Wound, Fatigue, Bursitis, Gastrointestinal disorder, Infection, Helicobacter infection, Pain in extremity, Hypersensitivity, Lower respiratory tract infection, Obesity, Oedema peripheral, Type 2 diabetes mellitus, Ill-defined disorder, Condition aggravated, Weight increased, Arthropathy, Liver disorder, Rheumatoid arthritis, Insomnia, Wound infection, Infusion related reaction, Wheezing, Facet joint syndrome, Sleep disorder due to general medical condition, insomnia type, Diarrhoea, Rheumatic fever, Urticaria, Stomatitis, Delirium, Rash, Psoriatic arthropathy, Impaired healing, Discomfort, Sinusitis, Dislocation of vertebra, Dyspnoea, Breast cancer stage III, Hypertension, Frequent bowel movements, Pericarditis, Arthralgia, Abdominal pain upper, Rheumatoid factor positive, Headache, Confusional state, Pruritus, Depression, Lip dry, Glossodynia, Rectal haemorrhage, Chest pain, |
||||
METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, LEFLUNOMIDE, LEFLUNOMIDE, ALENDRONATE SODIUM, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, PREDNISONE, PREDNISONE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, HYDROCORTISONE SODIUM SUCCINATE, HYDROCORTISONE SODIUM SUCCINATE, HYDROCORTISONE SODIUM SUCCINATE, CALCIUM GLUCONATE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, SECUKINUMAB, APREPITANT, APREPITANT, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, FISH OIL, USTEKINUMAB, ALENDRONATE SODIUM, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, SULFASALAZINE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, OXYCODONE HYDROCHLORIDE, OXYCODONE, OXYCODONE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, LANSOPRAZOLE, GOLIMUMAB, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, GOLIMUMAB, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ERGOCALCIFEROL, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOCILIZUMAB, ERGOCALCIFEROL, FOLIC ACID, FOLIC ACID, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, DESOGESTREL AND ETHINYL ESTRADIOL, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, RITUXIMAB-ABBS, RITUXIMAB-ABBS, LORAZEPAM, QUETIAPINE FUMARATE, QUETIAPINE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, SULFASALAZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, VEDOLIZUMAB, ADALIMUMAB, VITAMIN C, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, INDOMETHACIN, |
||||
1553 | 24895478 |
CA |
40 | 2 |
Abdominal discomfort, Facet joint syndrome, Hepatitis, Lower respiratory tract infection, Joint range of motion decreased, Osteoarthritis, C-reactive protein abnormal, Injury, C-reactive protein increased, Onychomadesis, Epilepsy, Breast cancer stage III, Blood cholesterol increased, Drug hypersensitivity, Nail disorder, Drug-induced liver injury, Obesity, Contraindicated product administered, Headache, General physical health deterioration, Depression, Onychomycosis, Diarrhoea, Glossodynia, Dizziness, Muscle spasms, Mobility decreased, Lip dry, Nasopharyngitis, Gait inability, Nausea, Helicobacter infection, Hepatic enzyme increased, Blister, Inflammation, Pain, Dyspepsia, Hypoaesthesia, Peripheral venous disease, Peripheral swelling, Folliculitis, Drug ineffective, Arthropathy, Pericarditis, Fibromyalgia, Confusional state, Infusion related reaction, Pemphigus, Irritable bowel syndrome, Pain in extremity, Asthenia, Insomnia, Off label use, Abdominal pain upper, Ill-defined disorder, Impaired healing, Coeliac disease, Grip strength decreased, Liver function test increased, Musculoskeletal stiffness, Dyspnoea, Back injury, Blepharospasm, Hypercholesterolaemia, Liver injury, Lung disorder, Paraesthesia, Arthralgia, Migraine, Gastrointestinal disorder, Bursitis, Adverse reaction, Maternal exposure during pregnancy, Finger deformity, Musculoskeletal pain, Hand deformity, Drug intolerance, Joint swelling, Neck pain, Injection site reaction, Abdominal distension, Malaise, Fatigue, Dry mouth, Night sweats, Hypersensitivity, Alopecia, Duodenal ulcer perforation, Condition aggravated, Hypotension, Muscle injury, Memory impairment, Anti-cyclic citrullinated peptide antibody positive, Fall, |
||||
METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, GOLD, MIRABEGRON, ERGOCALCIFEROL, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, OXYCODONE, INFLIXIMAB, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, CALCIUM CARBONATE, ANTACID, ATOMOXETINE, ATOMOXETINE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, SULFASALAZINE, DICLOFENAC, DICLOFENAC SODIUM, BOTULINUM TOXIN TYPE A, ERENUMAB-AOOE, AZATHIOPRINE SODIUM, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, METHYLPREDNISOLONE, USTEKINUMAB, USTEKINUMAB, LEFLUNOMIDE, LEFLUNOMIDE, NICOTINAMIDE, MINOCYCLINE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, BUPRENORPHINE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, MEPOLIZUMAB, SARILUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, RAMIPRIL, LAMOTRIGINE, LAMOTRIGINE, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, CANDESARTAN, HYDROXYCHLOROQUINE SULFATE, RANITIDINE, VITAMIN C, INFLIXIMAB, CELECOXIB, CELECOXIB, ALENDRONATE SODIUM, ALENDRONATE SODIUM, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, TRAMADOL HYDROCHLORIDE, HYDROXYCHLOROQUINE SULFATE, SECUKINUMAB, NAPROXEN, NAPROXEN SODIUM, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ETANERCEPT, ETANERCEPT, ETANERCEPT, METHOTREXATE, METHOTREXATE SODIUM, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, |
||||
1554 | 24895644 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
1555 | 24895661 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
1556 | 24895666 |
US |
65 | 1 |
Norovirus infection, Blood potassium decreased, General physical health deterioration, Infection, Norovirus infection, Abdominal pain upper, Dehydration, Fatigue, Diarrhoea, Neuropathy peripheral, Vomiting, |
||||
PANCRELIPASE, FAMOTIDINE, LORATADINE, LORATADINE TABLET, MONTELUKAST SODIUM, OXALIPLATIN, FLUTICASONE PROPIONATE, TRIPROLIDINE HCL, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
1557 | 24895674 |
CA |
40 | 2 |
Drug-induced liver injury, Abdominal discomfort, Abdominal pain upper, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Blood cholesterol increased, Bursitis, C-reactive protein increased, Confusional state, Decreased appetite, Fatigue, Dyspnoea, Folliculitis, Gastrointestinal disorder, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Hand deformity, Hepatic enzyme increased, Hypertension, Hypoaesthesia, Wound infection, Wheezing, Wound, Vomiting, Type 2 diabetes mellitus, Systemic lupus erythematosus, Synovitis, Mobility decreased, Joint swelling, Injection site reaction, Inflammation, Ill-defined disorder, Weight increased, Taste disorder, Urticaria, Maternal exposure during pregnancy, Drug intolerance, Treatment failure, Therapeutic product effect decreased, Therapeutic product effect incomplete, Off label use, |
||||
DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, DICLOFENAC, DICLOFENAC SODIUM, ADALIMUMAB-ADAZ, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, PHENYLEPHRINE HYDROCHLORIDE, ERGOCALCIFEROL, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, VITAMIN C, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, LEFLUNOMIDE, AZATHIOPRINE, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, CELECOXIB, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, HYDROCORTISONE, HYDROCORTISONE, CELECOXIB, CELECOXIB, ETANERCEPT, ETANERCEPT, ERENUMAB-AOOE, ERGOCALCIFEROL, ERGOCALCIFEROL, ERGOCALCIFEROL, GOLIMUMAB, GOLIMUMAB, INFLIXIMAB, SARILUMAB, LAMOTRIGINE, METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MIRABEGRON, NAPROXEN, NAPROXEN SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, MEPOLIZUMAB, PREDNISONE, PREDNISONE, RAMIPRIL, RANITIDINE HYDROCHLORIDE, SULFASALAZINE, APREMILAST, APREMILAST, APREMILAST, TOFACITINIB, TOPIRAMATE, TOPIRAMATE SPINKLE, TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, |
||||
1558 | 24895723 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
1559 | 24895781 |
CA |
65 | 1 |
Loss of consciousness, Pain in extremity, Neck pain, General physical health deterioration, Therapeutic product effect decreased, Off label use, |
||||
ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, EZETIMIBE, TAMSULOSIN HYDROCHLORIDE, HYDROXYCHLOROQUINE SULFATE, QUETIAPINE, TELMISARTAN, |
||||
1560 | 24895803 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
1561 | 24895962 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
1562 | 24895965 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
1563 | 24895987 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
1564 | 24895991 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
1565 | 24896048 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
1566 | 24896108 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
1567 | 24896134 |
DE |
1 | |
Thinking abnormal, Suicidal ideation, Electroencephalogram abnormal, Polydipsia, Rash, Depression, Nightmare, Panic attack, Drug ineffective, Tremor, Bradykinesia, Generalised tonic-clonic seizure, Seizure, General physical health deterioration, |
||||
ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, LACOSAMIDE, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, OXCARBAZEPINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, ZONISAMIDE, ETHOSUXIMIDE, |
||||
1568 | 24896270 |
US |
69 | 2 |
General physical health deterioration, |
||||
TRIFLURIDINE AND TIPIRACIL, |
||||
1569 | 24896312 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
1570 | 24896328 |
US |
1 | |
General physical health deterioration, Disease progression, Therapy non-responder, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
1571 | 24896953 |
US |
79 | 2 |
Death, Feeding disorder, Dysphagia, General physical health deterioration, |
||||
FOSCARBIDOPA/FOSLEVODOPA, |
||||
1572 | 24886870 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
1573 | 24887146 |
CA |
40 | 2 |
Drug-induced liver injury, Dizziness, Blister, Live birth, Arthropathy, Paraesthesia, Muscular weakness, Pemphigus, Fatigue, Hypoaesthesia, Nasopharyngitis, Drug intolerance, Migraine, Joint range of motion decreased, Injection site reaction, Lip dry, Blood cholesterol increased, Peripheral swelling, Osteoarthritis, Pericarditis, Back injury, Gastrooesophageal reflux disease, Depression, Rash, Hypertension, Fibromyalgia, Injury, Pain, Ill-defined disorder, Malaise, Bursitis, Fall, Epilepsy, Exposure during pregnancy, Onychomycosis, Maternal exposure during pregnancy, Inflammation, C-reactive protein increased, Facet joint syndrome, Hand deformity, Abdominal distension, Dyspnoea, Dyspepsia, Onychomadesis, Psoriatic arthropathy, Mobility decreased, Folliculitis, Irritable bowel syndrome, Glossodynia, General physical health deterioration, Nausea, Confusional state, Muscle spasms, Memory impairment, Swelling, Adverse reaction, Liver function test increased, Helicobacter infection, Contraindicated product administered, Hepatic enzyme increased, Headache, Hypercholesterolaemia, Musculoskeletal stiffness, Night sweats, Rheumatoid arthritis, Lower respiratory tract infection, Condition aggravated, Musculoskeletal pain, Drug ineffective, Neck pain, Sleep disorder, Liver injury, Arthralgia, Impaired healing, Blepharospasm, Coeliac disease, Infusion related reaction, Off label use, Abdominal discomfort, Breast cancer stage III, Muscle injury, Stomatitis, Gait inability, Joint swelling, Abdominal pain upper, Alopecia, Pain in extremity, Synovitis, Nail disorder, Intentional product use issue, Drug hypersensitivity, Obesity, Insomnia, C-reactive protein abnormal, Hypersensitivity, Rheumatic fever, Grip strength decreased, Finger deformity, Duodenal ulcer perforation, Diarrhoea, Pneumonia, Dry mouth, Peripheral venous disease, Anti-cyclic citrullinated peptide antibody positive, Lung disorder, Asthenia, Gastrointestinal disorder, Systemic lupus erythematosus, Hepatitis, |
||||
DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, CALCIUM CARBONATE, ANTACID, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, BUPRENORPHINE, TRANEXAMIC ACID, TRANEXAMIC ACID, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, SECUKINUMAB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, GOLD, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE SULFATE, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, APREMILAST, RAMIPRIL, RAMIPRIL, RAMIPRIL, RANITIDINE, INFLIXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, SULFASALAZINE, ATOMOXETINE HYDROCHLORIDE, ATOMOXETINE HYDROCHLORIDE, ATOMOXETINE HYDROCHLORIDE, CANDESARTAN CILEXETIL, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, VITAMIN C, ACETAMINOPHEN AND CODEINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ERENUMAB-AOOE, ERENUMAB-AOOE, ERENUMAB-AOOE, ERENUMAB-AOOE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, AZATHIOPRINE SODIUM, AZATHIOPRINE SODIUM, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ERGOCALCIFEROL, ERGOCALCIFEROL, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MINOCYCLINE, MINOCYCLINE, MINOCYCLINE, MIRABEGRON, MIRABEGRON, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NICOTINAMIDE, MEPOLIZUMAB, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, OXYCODONE, HYDROXYCHLOROQUINE SULFATE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, USTEKINUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TRAMADOL HYDROCHLORIDE, TOFACITINIB, TOFACITINIB, |
||||
1574 | 24887239 |
US |
34 | 2 |
General physical health deterioration, |
||||
DUPILUMAB, |
||||
1575 | 24887363 |
BR |
1 | |
General physical health deterioration, Crohn^s disease, Hypertension, Mobility decreased, Gait disturbance, Infection, Anaemia, Product dose omission issue, |
||||
USTEKINUMAB, USTEKINUMAB, |
||||
1576 | 24887377 |
CA |
2 | |
Systemic lupus erythematosus, Sleep disorder, Weight increased, Irritable bowel syndrome, Discomfort, Sinusitis, Hepatic enzyme increased, General physical health deterioration, Rash, Wound, Confusional state, Arthralgia, Pericarditis, Pruritus, Blister, Contusion, Pyrexia, Nasopharyngitis, Pemphigus, Abdominal discomfort, Synovitis, Insomnia, Hand deformity, Contraindicated product administered, Infection, Glossodynia, Sleep disorder due to general medical condition, insomnia type, Ill-defined disorder, Peripheral swelling, Muscle injury, Anti-cyclic citrullinated peptide antibody positive, Swelling, Impaired healing, Folliculitis, Pain, Hypersensitivity, Joint swelling, Lower respiratory tract infection, Injury, Gastrointestinal disorder, Stomatitis, Condition aggravated, Alopecia, Infusion related reaction, Dyspnoea, Duodenal ulcer perforation, Arthropathy, Fatigue, Helicobacter infection, Rheumatoid arthritis, |
||||
DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, APREPITANT, LEFLUNOMIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETRIMIDE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, HYDROCORTISONE, DESOXIMETASONE, ADALIMUMAB, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE SULFATE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, LEFLUNOMIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, ABATACEPT, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, ALENDRONATE SODIUM, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, ETANERCEPT, FOLIC ACID, FOSAPREPITANT, FOSAPREPITANT DIMEGLUMINE, OXYCODONE, PANTOPRAZOLE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, INFLIXIMAB, RITUXIMAB, GOLIMUMAB, USTEKINUMAB, SULFASALAZINE, SULFASALAZINE, TOFACITINIB, |
||||
1577 | 24887603 |
CA |
43 | 2 |
Lower respiratory tract infection, Drug ineffective, Muscle injury, Swelling, Vomiting, Maternal exposure during pregnancy, Migraine, Psoriatic arthropathy, Musculoskeletal pain, Hepatic enzyme, Stomatitis, Helicobacter infection, Lung disorder, Product quality issue, Muscle spasms, Alopecia, Dizziness, Hypoaesthesia, Rash, Condition aggravated, Obesity, Blepharospasm, Wound infection, Impaired healing, Type 2 diabetes mellitus, Rheumatoid arthritis, Bursitis, Discomfort, Hand deformity, Anti-cyclic citrullinated peptide antibody positive, Urticaria, Hypertension, Nasopharyngitis, Wheezing, Duodenal ulcer perforation, Systemic lupus erythematosus, Gastrooesophageal reflux disease, Infusion related reaction, Asthenia, Paraesthesia, Confusional state, Liver injury, Fibromyalgia, Wound, Facet joint syndrome, Abdominal pain upper, Abdominal pain, Product use in unapproved indication, Pemphigus, Inflammation, Arthralgia, Osteoarthritis, Taste disorder, Hypercholesterolaemia, General physical health deterioration, Peripheral swelling, Synovitis, Drug intolerance, Pericarditis, Diarrhoea, Weight increased, C-reactive protein increased, Dry mouth, Intentional product use issue, Folliculitis, Nail disorder, Peripheral venous disease, Fatigue, Blister, Glossodynia, Arthropathy, Memory impairment, Off label use, Pain, Irritable bowel syndrome, Night sweats, Lip dry, Joint swelling, Epilepsy, Breast cancer stage III, Abdominal discomfort, Blood cholesterol increased, Joint range of motion decreased, Depression, |
||||
METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, ABATACEPT, GOLIMUMAB, GOLIMUMAB, SECUKINUMAB, BUPRENORPHINE, ATOMOXETINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PREDNISONE, ALENDRONATE SODIUM, CELECOXIB, CELECOXIB, LAMOTRIGINE, GOLD, POVIDONE-IODINE, MIRABEGRON, RANITIDINE, TOFACITINIB, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, BOTULINUM TOXIN TYPE A, APREMILAST, FOLIC ACID, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, NAPROXEN, NAPROXEN SODIUM, ETANERCEPT, ETANERCEPT, INFLIXIMAB, DESOXIMETASONE, HYDROCORTISONE BUTYRATE, LEFLUNOMIDE, METHOTREXATE, METHOTREXATE SODIUM, SULFASALAZINE, TOCILIZUMAB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, RAMIPRIL, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, CALCIUM GLUCONATE, CERTOLIZUMAB PEGOL, LANSOPRAZOLE, OXYCODONE, CANDESARTAN, QUETIAPINE FUMARATE, QUETIAPINE, LORAZEPAM, ERENUMAB-AOOE, TRAMADOL HYDROCHLORIDE, TOPIRAMATE, TOPIRAMATE SPINKLE, LISINOPRIL, SULFASALAZINE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, RISEDRONATE SODIUM, RITUXIMAB, RITUXIMAB, RITUXIMAB, CERTOLIZUMAB PEGOL, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, HYDROXYCHLOROQUINE SULFATE, MEPOLIZUMAB, FISH OIL, CYANOCOBALAMIN, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ERENUMAB-AOOE, |
||||
1578 | 24887680 |
US |
62 | 1 |
Small intestinal obstruction, General physical health deterioration, Hernia, |
||||
LUTETIUM LU 177 DOTATATE, LUTETIUM LU 177 DOTATATE, CLOPIDOGREL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
1579 | 24887706 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
1580 | 24887944 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
1581 | 24887991 |
US |
55 | 1 |
General physical health deterioration, Productive cough, |
||||
CERTOLIZUMAB PEGOL, FISH OIL, LISINOPRIL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, NAPROXEN, NAPROXEN SODIUM, |
||||
1582 | 24888160 |
CA |
43 | 2 |
Breast cancer stage III, Synovitis, Lung disorder, Pemphigus, Folliculitis, Arthropathy, Epilepsy, Abdominal pain, Abdominal pain upper, Helicobacter infection, Muscle injury, Blood cholesterol increased, Intentional product use issue, Discomfort, Lip dry, Systemic lupus erythematosus, Nail disorder, Bursitis, Infusion related reaction, Confusional state, Nasopharyngitis, Wheezing, General physical health deterioration, C-reactive protein increased, Wound, Drug ineffective, Blister, Duodenal ulcer perforation, Drug intolerance, Fibromyalgia, Diarrhoea, Off label use, Paraesthesia, Peripheral swelling, Blepharospasm, Gastrooesophageal reflux disease, Depression, Wound infection, Psoriatic arthropathy, Arthralgia, Alopecia, Irritable bowel syndrome, Impaired healing, Glossodynia, Musculoskeletal pain, Rheumatoid arthritis, Pericarditis, Weight increased, Fatigue, Taste disorder, Dizziness, Urticaria, Product quality issue, Stomatitis, Facet joint syndrome, Obesity, Abdominal discomfort, Hypercholesterolaemia, Migraine, Hypoaesthesia, Asthenia, Product use in unapproved indication, Condition aggravated, Joint range of motion decreased, Anti-cyclic citrullinated peptide antibody positive, Memory impairment, Lower respiratory tract infection, Maternal exposure during pregnancy, Hepatic enzyme, Swelling, Inflammation, Osteoarthritis, Rash, Joint swelling, Hand deformity, Vomiting, Type 2 diabetes mellitus, Pain, Liver injury, Muscle spasms, Peripheral venous disease, Night sweats, Dry mouth, Hypertension, |
||||
GOLIMUMAB, GOLIMUMAB, TRAMADOL HYDROCHLORIDE, LORAZEPAM, LANSOPRAZOLE, ALENDRONATE SODIUM, CERTOLIZUMAB PEGOL, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, METHOTREXATE, METHOTREXATE SODIUM, RAMIPRIL, HYDROXYCHLOROQUINE SULFATE, RITUXIMAB, RITUXIMAB, GOLD, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, LAMOTRIGINE, MEPOLIZUMAB, BUPRENORPHINE, SULFASALAZINE, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, ATOMOXETINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, TOFACITINIB, CYANOCOBALAMIN, BOTULINUM TOXIN TYPE A, CELECOXIB, CELECOXIB, CALCIUM, TOCILIZUMAB, PREDNISONE, RISEDRONATE SODIUM, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ERENUMAB-AOOE, HYDROCORTISONE BUTYRATE, ABATACEPT, CANDESARTAN, MIRABEGRON, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, TOPIRAMATE, TOPIRAMATE SPINKLE, OXYCODONE, LEFLUNOMIDE, LISINOPRIL, FISH OIL, SECUKINUMAB, QUETIAPINE FUMARATE, QUETIAPINE, NAPROXEN, NAPROXEN SODIUM, INFLIXIMAB, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, ETANERCEPT, APREMILAST, RANITIDINE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, SULFASALAZINE, FOLIC ACID, |
||||
1583 | 24888319 |
FR |
92 | 2 |
Vomiting, General physical health deterioration, |
||||
DOXYCYCLINE, DOXYCYCLINE HYCLATE, |
||||
1584 | 24889200 |
DE |
54 | 2 |
Metastatic neoplasm, Metastatic bronchial carcinoma, Non-small cell lung cancer metastatic, EGFR gene mutation, Hypokalaemia, Metastatic squamous cell carcinoma, Metastases to bone, Brain oedema, Metastases to lung, Cerebral haemorrhage, Delirium, Hypercalcaemia of malignancy, Humerus fracture, Pleural effusion, General physical health deterioration, Dyspnoea exertional, Arthralgia, |
||||
TERIFLUNOMIDE, DALTEPARIN SODIUM, FUROSEMIDE, TORSEMIDE, PREGABALIN, AMITRIPTYLINE HYDROCHLORIDE, |
||||
1585 | 24889485 |
FR |
69 | 2 |
Immune-mediated enterocolitis, General physical health deterioration, |
||||
CARBOPLATIN, PACLITAXEL, DOSTARLIMAB, |
||||
1586 | 24889711 |
CA |
30 | 1 |
Crohn^s disease, General physical health deterioration, General physical condition abnormal, Abdominal pain, Drug effect less than expected, Product use issue, |
||||
ADALIMUMAB-ADAZ, |
||||
1587 | 24889719 |
CA |
54 | 1 |
Neoplasm malignant, Contusion, Back pain, Pain in extremity, Rash papular, General physical health deterioration, Arthralgia, Androgen deficiency, Injection site pain, Injection site mass, Injection site bruising, |
||||
CYCLOBENZAPRINE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, INDOMETHACIN, INDOMETHACIN, GOLIMUMAB, |
||||
1588 | 24889819 |
PL |
49 | 1 |
Electrocardiogram abnormal, General physical health deterioration, Dyspnoea, Rales, Fatigue, Rales, |
||||
CARVEDILOL, CARVEDILOL, BISOPROLOL FUMARATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, RAMIPRIL, RAMIPRIL, SACUBITRIL AND VALSARTAN, SACUBITRIL AND VALSARTAN, EPLERENONE, EPLERENONE, FENOFIBRATE, FENOFIBRATE, EZETIMIBE, ROSUVASTATIN, |
||||
1589 | 24889983 |
CA |
2 | |
Uveitis, Arthralgia, Faeces soft, General physical health deterioration, Off label use, |
||||
ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, |
||||
1590 | 24890099 |
US |
1 | |
Insomnia, General physical health deterioration, Affect lability, Off label use, |
||||
ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR, |
||||
1591 | 24890265 |
DE |
72 | 2 |
General physical health deterioration, Decreased appetite, Haematemesis, Large intestinal stenosis, Ileus, Pneumonitis, Pneumonia, C-reactive protein increased, General physical health deterioration, |
||||
CARBOPLATIN, PACLITAXEL, PEMBROLIZUMAB, |
||||
1592 | 24890334 |
CA |
||
Activated partial thromboplastin time prolonged, Anaemia, Analgesic therapy, Antacid therapy, Anticoagulant therapy, Aspiration, Asthenia, Asthma, Bacterial infection, Benign prostatic hyperplasia, Blood calcium increased, Blood creatinine increased, Blood test abnormal, Breath sounds abnormal, Bronchopulmonary aspergillosis allergic, Cardiovascular disorder, Condition aggravated, Congenital hiatus hernia, Coronary artery disease, Death, Diabetes mellitus, Drug hypersensitivity, Drug ineffective, Drug intolerance, Drug therapy, End stage renal disease, Fatigue, Full blood count abnormal, Gastrointestinal disorder, General physical health deterioration, Gout, Headache, Hypercholesterolaemia, Hyperlipidaemia, Hyperphosphataemia, Hypertension, Hyponatraemia, Hypophosphataemia, Joint injury, Liver disorder, Lower respiratory tract infection, Lung disorder, Malignant melanoma in situ, Micturition urgency, Multiple organ dysfunction syndrome, Musculoskeletal stiffness, Myasthenia gravis, Neuralgia, Oedema peripheral, Pain, Pleuritic pain, Pulmonary embolism, Pyrexia, Respiratory symptom, Sepsis, Sleep disorder, Sleep disorder therapy, Somnolence, Stress, Swelling, Thrombosis, Transaminases increased, Transient ischaemic attack, Tremor, Troponin increased, Ulcer, Upper respiratory tract infection, Intentional product misuse, Incorrect route of product administration, Off label use, Product dose omission issue, Product use in unapproved indication, |
||||
ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, BUDESONIDE, HYDROCORTISONE ACETATE, EFINACONAZOLE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, EFINACONAZOLE, EFINACONAZOLE, MESALAMINE, METRONIDAZOLE, METRONIDAZOLE TOPICAL, METRONIDAZOLE, METRONIDAZOLE TOPICAL, METRONIDAZOLE, METRONIDAZOLE TOPICAL, NITROGLYCERIN, PHYTONADIONE, PHYTONADIONE, PHYTONADIONE, RAMIPRIL, RAMIPRIL, |
||||
1593 | 24890387 |
DE |
1 | |
Bradykinesia, Tremor, Seizure, Electroencephalogram abnormal, Rash, Drug ineffective, General physical health deterioration, Polydipsia, Panic attack, Nightmare, Depression, Suicidal ideation, Generalised tonic-clonic seizure, Thinking abnormal, |
||||
LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, LACOSAMIDE, ETHOSUXIMIDE, OXCARBAZEPINE, ZONISAMIDE, |
||||
1594 | 24890501 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 DOTATATE, |
||||
1595 | 24890725 |
BR |
||
Epilepsy, Respiratory disorder, General physical health deterioration, Nasopharyngitis, Malaise, |
||||
ELOSULFASE ALFA, |
||||
1596 | 24890972 |
CO |
95 | 2 |
General physical health deterioration, Dementia, |
||||
VALSARTAN, |
||||
1597 | 24890997 |
US |
44 | 2 |
General physical health deterioration, |
||||
DUPILUMAB, GLIMEPIRIDE, CYANOCOBALAMIN, ERGOCALCIFEROL, LOSARTAN POTASSIUM, LOSARTAN, BUPROPION HYDROCHLORIDE, LAMOTRIGINE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, SEMAGLUTIDE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, LEVALBUTEROL TARTRATE, PREDNISONE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, |
||||
1598 | 24891143 |
US |
2 | |
General physical health deterioration, |
||||
DUPILUMAB, |
||||
1599 | 24891412 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
1600 | 24891948 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28